So far, further investigations are required to answer a few important questions, such as the role of epigenetic alterations in FSHD, whether hypomethylation leads to DUX4 activation and, above all, how this translates into a specific muscle phenotype. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.